Updates are available Correction dated 2023-08-18
Click to view Correction: https://doi.org/10.1007/s00198-023-06887-4
-
Authors
Everts-Graber, Judith http://orcid.org/0000-0002-8792-8199
Bonel, Harald
Lehmann, Daniel
Gahl, Brigitta http://orcid.org/0000-0001-8123-0438
Häuselmann, HansJörg
Studer, Ueli
Ziswiler, Hans-Rudolf
Reichenbach, Stephan http://orcid.org/0000-0001-8098-6567
Lehmann, Thomas http://orcid.org/0000-0003-0739-5562
-
Funding
Funding for this research was provided by:
Campus Stiftung Lindenhof Bern (Bonel_21-01_Netz_AFF)
University of Bern
- License Information
-
More Information
Article History
Received: 21 November 2022
Accepted: 13 July 2023
First Online: 26 July 2023
Change Date: 18 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00198-023-06887-4
Declarations
:
: JE, DL, BG, SR and TL have nothing to declare and no conflicts of interest. HB received consultancy fees from Novartis. HJH received occasional speaker’s fees from Amgen, Sandoz, Eli Lilly and Labatec. HRZ received consultancy fees from Abbvie, Celgene, Amgen and Mylan/Viatris. US received congress and travel expenses from Sandoz, Pfizer and Janssen Pharmaceutica, and consultancy fees from Novartis and Amgen.
